BioCentury
ARTICLE | Clinical News

ToleroMune Cat Dander: Phase II data

September 15, 2008 7:00 AM UTC

A double-blind, placebo-controlled, German Phase II trial in 88 subjects showed single doses of ToleroMune produced a significant reduction in allergic reactions to cat dander. Patients were administe...